Catalytic activity of antibodies against factor VIII in patients with hemophilia A
- 1 September 1999
- journal article
- research article
- Published by Springer Nature in Nature Medicine
- Vol. 5 (9) , 1044-1047
- https://doi.org/10.1038/12483
Abstract
Hemophilia A is an X chromosome-linked recessive disorder resulting in defective or deficient factor VIII (FVIII) molecules, which, in its severe form, is a life-threatening and crippling hemorrhagic disease. Infusion of homologous FVIII to patients with severe hemophilia A results, in 25% of patients, in the emergence of alloantibodies against FVIII (inhibitors)(ref. 1) that inhibit FVIII procoagulant activity by steric hindrance of the interaction of FVIII either with stabilizing molecules2, with molecules essential for its activity3,4 or with activating molecules5. Here, we report on the proteolysis of FVIII by alloantibodies of two patients with severe hemophilia A, demonstrating a previously unknown mechanism by which FVIII inhibitors may prevent the pro-coagulant function of FVIII. The kinetic parameters of FVIII hydrolysis indicate a functional role for the catalytic immune response in the inactivation of FVIII in vivo. The characterization of alloantibodies against FVIII as site-specific proteases may provide new approaches to the treatment of FVIII inhibitors.Keywords
This publication has 25 references indexed in Scilit:
- Slowed Release of Thrombin-cleaved Factor VIII from von Willebrand Factor by a Monoclonal and a Human Antibody Is a Novel Mechanism for Factor VIII InhibitionPublished by Elsevier ,1996
- Antibodies to a conserved region of HLA class I molecules, capable of modulating CD8 T cell-mediated function, are present in pooled normal immunoglobulin for therapeutic use.Journal of Clinical Investigation, 1996
- Guidelines for therapy and optimal dosages of coagulation factors for treatment of bleeding and surgery in haemophiliaHaemophilia, 1995
- DNA‐specific antiidiotypic antibodies in the sera of patients with autoimmune diseasesFEBS Letters, 1992
- Inactivation of factor VIII by factor IXaBiochemistry, 1992
- Incidence of development of factor VIII and factor IX inhibitors in haemophiliacsThe Lancet, 1992
- Inactivation of human factor VIII by activated protein C. Cofactor activity of protein S and protective effect of von Willebrand factor.Journal of Clinical Investigation, 1988
- Construction and characterization of an active factor VIII variant lacking the central one-third of the moleculeBiochemistry, 1986
- Proteolytic processing of human factor VIII. Correlation of specific cleavages by thrombin, factor Xa, and activated protein C with activation and inactivation of factor VIII coagulant activityBiochemistry, 1986
- Activation of porcine factor VIII:C by thrombin and factor XaBiochemistry, 1985